Refine
Is part of the Bibliography
- yes (10947) (remove)
Year of publication
Document Type
- Journal article (7659)
- Doctoral Thesis (2805)
- Preprint (107)
- Conference Proceeding (104)
- Book article / Book chapter (90)
- Review (43)
- Working Paper (40)
- Report (27)
- Master Thesis (26)
- Book (20)
Language
- English (10947) (remove)
Keywords
- Toxikologie (119)
- Medizin (99)
- inflammation (93)
- Psychologie (86)
- Biochemie (85)
- cancer (81)
- Organische Chemie (68)
- gene expression (68)
- Anorganische Chemie (66)
- Maus (64)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (1913)
- Graduate School of Life Sciences (802)
- Physikalisches Institut (596)
- Institut für Psychologie (494)
- Neurologische Klinik und Poliklinik (388)
- Medizinische Klinik und Poliklinik II (377)
- Institut für Organische Chemie (367)
- Medizinische Klinik und Poliklinik I (360)
- Institut für Molekulare Infektionsbiologie (355)
- Institut für Anorganische Chemie (354)
Schriftenreihe
- Cultural Animal Studies, Band 3 (2)
- Berichte aus der Informatik (1)
- Deuterocanonical and Cognate Literature Studies (1)
- Deuterocanonical and Cognate Literature Yearbook (1)
- International Archives of the History of Ideas / Archives internationales d’histoire des idées 242 (1)
- Methods in Molecular Biology 2533 (1)
- Methods in Molecular Biology; 2643 (1)
Sonstige beteiligte Institutionen
- Johns Hopkins School of Medicine (17)
- Helmholtz Institute for RNA-based Infection Research (HIRI) (7)
- IZKF Nachwuchsgruppe Geweberegeneration für muskuloskelettale Erkrankungen (7)
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (5)
- Fraunhofer-Institut für Silicatforschung ISC (5)
- Johns Hopkins University School of Medicine (5)
- Wilhelm-Conrad-Röntgen-Forschungszentrum für komplexe Materialsysteme (5)
- Bernhard-Heine-Centrum für Bewegungsforschung (4)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (4)
- Zentraleinheit Klinische Massenspektrometrie (4)
ResearcherID
- B-1911-2015 (1)
- B-4606-2017 (1)
- C-2593-2016 (1)
- D-1221-2009 (1)
- D-1250-2010 (1)
- I-5818-2014 (1)
- J-8841-2015 (1)
- M-1240-2017 (1)
- N-2030-2015 (1)
- N-3741-2015 (1)
As a traditional industrial pigment, perylene bisimide (PBI) dyes have found wide-spread applications. In addition, PBI dyes have been considered as versatile and promising functional materials for organic-based electronic and optic devices, such as transistors and solar cells. For these novel demands, the control of self-organization of this type of dye and the investigation of the relationship between the supramolecular structure and the relevant optical and electronic properties is of great importance. The objective of this thesis focuses on gaining a better understanding of structural and functional properties of pi-stacks based on self-assembling PBIs. Studies include the synthesis and characterization of new functional PBI dyes, their aggregation in solution, in liquid crystalline state and on surfaces, and their fluorescence and charge transport properties. An overview of the formation, thermodynamics and structures of pi-stacks of functional pi- conjugated molecules in solution and in liquid crystalline phases is given in Chapter 2. Chapters 3 and 4 deal with the pi-pi aggregates of new, highly fluorescent PBIs without core-substituents. In Chapter 3, the self-assembly of a PBI with tridodecylphenyl substituents at imide N atoms both in solution and condensed phase has been studied in great detail. In condensed state, the dye exhibits a hexagonal columnar liquid crystalline (LC) phase as confirmed by DSC, OPM and X-ray diffraction analysis. The columnar stacking of this dye has been further confirmed by atomic force microscopy (AFM) where single columns could be well resolved The charge transport properties this dye have been investigated by pulse radiolysis-time resolved microwave conductivity (PR-TRMC) measurements. To shed more light on the nature of the pi-pi interaction of the unsubstituted PBIs, solvent depend aggregation properties have been investigated in Chapter 4. The studies are further extended from core-unsubstituted PBIs to core-substituted ones (Chapter 5 and 6). In Chapter 5, a series of highly soluble and fluorescent core-twisted PBIs that bear the same trialkylphenyl groups at the imide positions but different bay-substituents and were synthesized. These compounds are characterized by distortions of the perylene planes with dihedral angles in the range of 15-37° according to crystallographic data and molecular modeling studies. In contrast to the extended oligomeric aggregates formed for planar unsubstituted PBIs, this family of dyes formed discrete pi-pi-stacked dimers in apolar methylcyclohexane as concentration-dependent UV/Vis measurements and VPO analysis revealed. The Gibbs free energy of dimerization can be correlated with the twist angles of the dyes linearly. In condensed state, several of these PBIs form luminescent rectangular or hexagonal columnar liquid crystalline phases with low isotropization temperatures. The core-twisting effect on semiconducting properties has been examined in Chapter 6. In this chapter, a comparative study of the electrochemical and the charge transport properties of a series of non-substituted and chlorine-functionalized PBIs was performed. While Chapters 3-6 focus on one-component dye systems, Chapter 7 explored the possibility of a supramolecular engineering of co-aggregates formed by hydrogen-bonded 2:1 and 1:1 complex of oligo(p-phenylene vinylene)s (OPVs) and PBIs. Covalently linked donor-acceptor dye arrays have been prepared for comparison. Concentration and temperature-dependent UV/Vis spectroscopy revealed all hydrogen-bonded and covalent systems form well-ordered J-type aggregates in methylcyclohexane. With these hydrogen-bonded OPV-PBI complexes, fibers containing p-type and n-type molecules can be prepared on the nano-scale (1-20 nm). For the 2:1 OPV-PBI hydrogenbonded arrays hierarchically assembled chiral superstructures consisting of left-handed helical pi-pi co-aggregates (CD spectroscopy) of the two dyes that further assemble into right-handed nanometer-scale supercoils in the solid state (AFM study) have been observed. All of these well-defined OPV-PBI assemblies presented here exhibit photoinduced electron transfer on sub-ps timescale, while the electron recombination differs for different systems.Thus, it was suggested that such assemblies of p- and n-type semiconductors might serve as valuable nanoscopic functional units for organic electronics.
In this work we utilized Density Functional Theory to calculate EPR parameters and spin-density distributions of several transition metal complexes. To demonstrate the performance of our theoretical approach several validation studies were performed (Chapters 3-5). In contrast, the last three chapters of the thesis deal with specific chemical problems regarding several classes of biologically relevant transition metal complexes.
Effects of desialyation on TCR-cross-linking and antigen sensitivity of CD8 positive T lymphocytes
(2005)
The featured experiments focus on changes in T cell membrane glycosylation as a possible means of controlling TCR cross-linking. Taking the long known fact that activated T cells show decreased levels of surface sialic acid as a starting point, differences in ligand binding and cellular reaction upon in vitro stimulation were investigated in naïve, activated and enzymatically desialyated CD8+, 2C TCR transgenic mouse lymphocytes. To detect differences in ligand binding lymphocytes were incubated with various concentrations of fluorescently labeled, soluble MHC/Ig fusion proteins until equilibrium was reached. Without previous washing, cells were analyzed by flow cytometry, determined MCF values were normalized to the plateau and fit to a mathematical model of equilibrium binding of divalent ligands to monomorphic receptors (Perelson 1984). Parameters derived from the model fit of binding data show, that neuraminidase treatment of T cells was sufficient to mimic a partially activated phenotype, showing enhanced TCR cross-linking. Enhanced TCR cross-linking was found to be dependent on the presence of CD8, as neuraminidase treatment of DN cells lead to decreased cross-linking. To elucidate the physiological relevance of desialyation induced increases in TCR cross-linking early tyrosine phosphorylation events and proliferative response upon in vitro stimulation of T cells were investigated. Both were found enhanced in neuraminidase treated cells, as compared to native cells. In conclusion the featured experiments suggest a role of surface sialic acid in controlling TCR cross-linking on naïve and activated T cells.
The aim of this study was to assess distribution patterns of articulate brachiopods during the Mesozoic. Exploratory and confirmatory multivariate analyses in this study evaluate whether environmental preferences of brachiopods and bivalves are substantially distinct and whether structure of their communities significantly differ. Specifically, the hypothesis being tested is that differential abundances of Mesozoic brachiopods and bivalves are not related to varying substrate properties only, but also to varying food supply, turbidity and oxygen levels. This hypothesis was evaluated with quantitative data gathered in various field areas and time intervals. They include the Upper Triassic deposits of the West Carpathians and Eastern Alps, the Lower and Middle Jurassic deposits of Morocco, the Middle and Upper Jurassic deposits of the West Carpathians, the Upper Jurassic deposits of the Franconian and Swabian Alb, and the Upper Jurassic deposits of the Swiss Jura. The main conclusion is that brachiopod-dominated communities are characterized by a unique guild structure, with dominance of trophic groups with low metabolic requirements or adapted to nutrient-poor or oxygen-poor conditions. For example, brachiopod co-occured more commonly with epifaunal than with infaunal bivalves in soft-bottom environments. Abundances of brachiopods correlate mostly negatively with increasing proportions of terrigenous admixture (i.e., with increasing amount of land-derived nutrient supply and turbidity).
Visualization of type I immunity using bicistronic IFN-gamma reporter mice in vitro and in vivo
(2006)
IFN-γ is the signature cytokine of Th1 and CD8+ effector cells generated in type I immune responses against pathogens, such as Influenza virus, Sendai virus and the intracellular protozoan parasite Toxoplasma gondii. Understanding the regulation of IFN-γ is critical for the manipulation of immune responses, prevention of immunopathology and for vaccine design. In the present thesis, IFN-γ expression by CD4+ and CD8+ T cells was characterized in detail and the requirement of IFN-γ receptor mediated functions for IFN-γ expression was assessed. Bicistronic IFN-γ-eYFP reporter mice, which allow direct identification and isolation of live IFN-γ expressing cells, were used to visualize IFN-γ expression in vitro and in vivo after infection with the afore mentioned pathogens. Expression of the IFN-γ-eYFP reporter by CD4+ and CD8+ T cells was broadly heterogeneous in vitro and in vivo after infection. Increased expression of the reporter correlated positively with the abundance of IFN-γ transcripts and IFN-γ protein production upon stimulation. eYFP reporter brightness reflected the potential for IFN-γ production, but actual secretion was largely dependent on antigenic stimulation. Increased expression of the reporter also correlated with enhanced secretion of additional proinflammatory cytokines and chemokines and cell surface expression of markers that indicate recent activation. Highly eYFP fluorescent cells were generally more differentiated and their anatomical distribution was restricted to certain tissues. The anatomical restriction depended on the pathogen. IFN-γ expressing CD4+ and CD8+ T cells were generated in IFN-γ receptor deficient reporter mice after infection with Sendai virus or Toxoplasma gondii. However, in the absence of IFN-γ receptor mediated functions, the frequency and brightness of the eYFP reporter expression was altered. Dual BM chimeric mice, reconstituted with wild-type and IFN-γ receptor deficient reporter BM, revealed a T cell-intrinsic requirement for the IFN-γ receptor for optimal IFN-γ expression. Reporter fluorescence intensities were regulated independently of IFN-γ receptor mediated functions. Finally, we propose a model for IFN-γ expression by CD4+ and CD8+ T cells. 2. SUMMARY 10 In summary, the expression of IFN-γ is differentially regulated in CD4+ and CD8+ T cells and after viral or protozoan infections. Additionally, the role of IFN-γ receptor mediated functions for the expression of IFN-γ was determined.
The theoretical work presented in this thesis is concerned with the highest possible oxidation states of the 5d transition metal row. Based on a validation study of several DFT functionals against accurate coupled-cluster CCSD(T) methods we will present calculations on a series of new high oxidation state HgIV species. Quantum-chemical calculations have also been applied to various fluoro complexes of gold in oxidation states +V through +VII to evaluate the previously claimed existence of AuF7. The calculations indicate clearly that the oxidation state (+V), e.g., in [AuF5]2, remains the highest well-established gold oxidation state. Further calculations on iridium in oxidation state (+VII) show that IrF7 and IrOF5 are viable synthetic targets, whereas higher oxidation states of iridium appear to be unlikely. Structures and stabilities of several osmium fluorides and oxyfluorides were also studied in this thesis. It is shown that homoleptic fluorides all the way up to OsF8 may exist. Combining the results of the most accurate quantum-chemical predictions of this thesis and of the most reliable experimental studies, we observe a revised trend of the highest oxidation states of the 5d transition metal row. From lanthanum (+III) to osmium (+VIII), there is a linear increase of the highest oxidation states with increasing atomic number. Thereafter, we observe a linear descent from osmium (+VIII) to mercury (+IV). We will also present a short outlook to the transition metals of the 3d and 4d row and their highest reachable oxidation states.
Best disease, also termed vitelliform macular dystrophy type 2, VMD2, (OMIM #153700), is an autosomal dominant, early onset macular dystrophy associated with a remarkable accumulation of lipofuscin-like material within and beneath the retinal pigment epithelium (RPE). The VMD2 gene mutated in Best disease encodes a 585 amino acid putative transmembrane protein named bestrophin, and is preferentially expressed in the RPE. The protein has a complex membrane topology with 4-6 putative transmembrane domains (TMDs) and is presumably involved in Ca2+-dependent transport of chloride ions across the membrane. The vast majority of known disease-associated alterations are missense mutations nonrandomly distributed across the highly conserved N-terminal half of the protein with clusters near the predicted TMDs. The mechanism connecting Best disease pathology with the identified mutations or the Cl- channel function is not yet clear. To further elucidate the biological function of the bestrophin protein and to identify the molecular mechanisms underlying the disease, a search for interacting partners of bestrophin was performed using the GAL4-based yeast two hybrid system (Y2H). Screening of a bovine RPE cDNA library with various truncated bestrophin baits resulted in the identification of 53 putative interacting partners of bestrophin. However, verification of the interaction has excluded all candidate clones. Our comprehensive Y2H analyses suggest that bestrophin may not be suitable for traditional yeast two hybrid screens likely due to the fact that the protein is integral to the membrane and even fragments thereof may not be transported to the nucleus which is, however a prerequisite for protein interaction in the yeast system. Bestrophin belongs to a large family of integral membrane proteins with more than 100 members identified to date originating from evolutionarily diverse organisms such as mammals, insects and worms. The most distinctive feature of the bestrophin family, besides the invariant RFP (arginine-phenylalanine-proline) domain, is an evolutionarily highly conserved N-terminal region. To clarify the phylogenetic relationship among bestrophin homologues and to identify structural and functional motifs conserved across family members, a bioinformatics/phylogenetic study of the conserved N-terminal region was conducted. Phylogenetic analysis of the bestrophin homologues reveals existence of four evolutionary conserved family members in mammals, with high homology to the human VMD2, VMD2-L1 to L3 proteins. The significant level of protein sequence similarity between divergent species suggests that each of the bestrophin family members has a unique, Chapter One: Summary 2 evolutionarily conserved function and that the divergence of bestrophin into several family members occurred before the divergence of individual mammalian species.
There are numerous areas of application for which PKPD models are a valuable tool. We studied dose linearity, bone penetration and drug-drug interactions of antibiotics by PKPD modeling. Knowledge about possible saturation of elimination pathways at therapeutic concentrations is important for studying the probability of successful treatment of dosage regimens via MCS at various doses, other modes of administration, or both. We studied the dose linearity of flucloxacillin and piperacillin. For data analysis of the dose linearity studies, population PK modeling and MCS was used. Population PK has been reported to detect saturable elimination at lower doses, and to estimate BSV more precisely than the STS approach. The variability in PK and the expected variability in PD are combined in a MCS to predict the probability of successful treatment. Flucloxacillin showed no saturation of elimination at the studied doses of 500 mg and 1000 mg. Comparison of various dosage regimens showed, that only one third of the daily dose is needed with prolonged or continuous infusion to achieve the same probability of successful treatment as short-term infusions at the full dose. For serious infections with sensitive staphylococci that are treated with intravenous flucloxacillin, prolonged infusion and continuous infusion are an appealing treatment option. Contrary to flucloxacillin, renal elimination and to a lesser extent also nonrenal elimination of piperacillin were saturable at therapeutic concentrations. Renal clearance decreased by 24% (p = 0.02) after a dose of 3000 mg piperacillin compared to the 1500 mg dose. A model without saturable elimination predicted PTA expectation values that were 6 to 11% lower for high dose short-term infusions and 2 to 5% higher for low dose continuous infusions, compared to models with saturable elimination. These differences depend on the MIC distributions of the local hospital. However, more accurate estimates for the PTA expectation value can be obtained by including an existent saturable elimination pathway into the PK model. Developing a mechanistic model of an interaction allows one to predict the extent of the interaction for other doses of drug and inhibitor. We studied the interactions between gemifloxacin and probenecid, between ciprofloxacin, its metabolite M1 and probenecid, and between flucloxacillin and piperacillin. Mechanistic models for drug-drug interactions were developed by the STS approach. This approach directly accounts for the concentration dependence of an interaction and describes the full time course of an interaction. Probenecid significantly inhibited the renal elimination of gemifloxacin, ciprofloxacin and ciprofloxacin’s metabolite M1, and slightly decreased nonrenal clearance of gemifloxacin. Piperacillin significantly decreased renal and nonrenal clearance of flucloxacillin, but hardly vice versa. For all three interactions competitive inhibition of a capacity-limited renal elimination pathway was identified as the most likely mechanism. As those drugs are all actively secreted in the renal tubules, competitive interaction is physiologically reasonable. Probenecid had a lower affinity to the renal transporter than gemifloxacin, ciprofloxacin and M1. Due to its substantially higher concentrations, probenecid inhibited the elimination of the quinolones. The affinity of piperacillin for the renal transporter was 13 times higher compared to flucloxacillin. Piperacillin PK was only slightly affected by flucloxacillin. PK interactions with piperacillin are likely to occur also with other betalactam combinations. PK interactions may be useful to improve the PD profile of an antibiotic, however possibly increased risks for side effects (e.g. risk of rash for gemifloxacin and probenecid) have to be considered.
Background: Population pharmacokinetic-pharmacodynamic (PKPD) modeling and simulations were applied to identify optimal dosage regimens for antibiotics. As the emergence of bacterial resistance is increasing and as only a few new antibiotics became available during the last decade, optimal use of established agents and preserving their effectiveness seems vital. Objectives: 1) To find the descriptor of body size and body composition which allows to achieve target concentrations and target effects in patients with cystic fibrosis (CF) most precisely. 2) To identify the mode of administration with the highest probability of successful treatment for intravenous beta-lactams. 3) To develop formulas for optimal dose selection for patients of various body size. General methods: Drug analysis in plasma and urine was performed by HPLC or LC-MS/MS in a single laboratory, at the IBMP. Drug analysis was not done by the author of this thesis. We used non-compartmental analysis and parametric population PK analysis for all studies. We used non-parametric bootstrapping to assess the uncertainty of PK parameters for our meta-analysis of the PK in CF-patients and healthy volunteers. Plasma concentration time profiles for several thousand virtual subjects were simulated by MCS which account for average PK parameters, their between subject variability (BSV), and patient specific demographic data. Convincing literature data show that the duration of non-protein bound concentration above MIC (fT>MIC) best predicts the microbiological and clinical success of beta-lactams and the area under the non-protein bound concentration curve divided by the MIC (fAUC/MIC) best predicts success for quinolones. We used PKPD targets from literature that were based on the fT>MIC or fAUC/MIC, respectively. Achieving a PKPD target was used as a surrogate measure for successful treatment. In our MCS, we calculated the fT>MIC or fAUC/MIC for all simulated concentration profiles and compared it to the value of the PKPD target. The fraction of subjects who achieved the target at the respective MIC approximates the probability of target attainment (PTA). The PTA can be interpreted as probability of successful treatment under certain assumptions. Studies in CF-patients Methods: We had data from ten studies (seven beta-lactams and three quinolones) in CF-patients which all included a healthy volunteer control group. Clinical procedures were very similar for all ten studies. Both subject groups had study conditions as similar as possible. We had data on 90 CF-patients (average +/- SD, age: 21+/-3.6 yrs) and on 111 healthy volunteers (age: 25+/-3.5 yrs). We compared the average clearance and volume of distribution between CF-patients and healthy volunteers for various body size descriptors including total body weight (WT), fat-free mass (FFM), and predicted normal weight (PNWT). We considered linear and allometric scaling of PK parameters by body size and used a meta-analysis based on population PK parameters for the comparison of CF-patients and healthy volunteers. Target concentrations can be achieved more precisely, if a size descriptor reduces the random, unexplained BSV. Therefore, we studied the reduction of unexplained BSV for each size descriptor relative to linear scaling by WT, since doses for CF-patients are commonly selected as mg/kg WT. Results: Without accounting for body size, average total clearance was 15% lower (p=0.005) and volume of distribution at steady-state was 17% lower (p=0.001) in CF-patients compared to healthy volunteers. For linear scaling by WT, average total clearance in CF-patients divided by total clearance in healthy volunteers was 1.15 (p=0.013). This ratio was 1.06 (p=0.191) for volume of distribution. A ratio of 1.0 indicates that CF-patients and healthy volunteers of the same body size have identical average clearances or volumes of distribution. For allometric scaling by FFM or PNWT, the ratio of total clearance and volume of distribution between CF-patients and healthy volunteers was within 0.80 and 1.25 for almost all drugs and the average ratio was close to 1. Allometric scaling by FFM or PNWT reduced the unexplained BSV in renal clearance by 24 to 27% (median of 10 drugs) relative to linear scaling by WT. The unexplained BSV was reduced for seven or eight of the ten drugs by more than 15% and the remaining two or three drugs had essentially unchanged (+/-15%) unexplained BSVs in renal clearance. Conclusions: The PK in CF-patients was comparable to the PK in healthy volunteers after accounting for body size and body composition by allometric scaling with FFM or PNWT. Target concentrations and target effects in CF-patients can be achieved most precisely by dose selection based on an allometric size model with FFM or PNWT. Future studies are warranted to study the clinical superiority of allometric dosing by FFM or PNWT compared to dose selection as mg/kg WT in CF-patients.